An Engineered RNase P Ribozyme Effectively Reduces Human Coronavirus 229E Gene Expression and Growth in Human Cells
The human coronavirus 229E (HCoV-229E) is a member of the human coronavirus family that includes SARS-CoV-2, the causative agent of COVID-19. Developing antiviral strategies and compounds is crucial to treat and prevent HCoV-229E infections and the associated diseases. Ribozymes derived from ribonuc...
Saved in:
| Main Authors: | Yujun Liu, Bin Yan, Hao Gong, Fenyong Liu |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2025-05-01
|
| Series: | Zoonotic Diseases |
| Subjects: | |
| Online Access: | https://www.mdpi.com/2813-0227/5/2/12 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Sustainable Polyphenol-Rich Extracts from Agricultural By-Products: Infectivity Inhibition Potential for Human Coronavirus 229E
by: Joan Teichenné, et al.
Published: (2025-04-01) -
Preferential cleavage of the coronavirus defective viral genome by cellular endoribonuclease with characteristics of RNase L
by: Ching-Hung Lin, et al.
Published: (2024-11-01) -
The interplay between emerging human coronavirus infections and autophagy
by: Zhenyu Zhao, et al.
Published: (2021-01-01) -
RNase P cleavage of pseudoknot substrates reveals differences in active site architecture that depend on residue N-1 in the 5’ leader
by: David M. Kosek, et al.
Published: (2025-12-01) -
Antisense technology as a potential strategy for the treatment of coronaviruses infection: With focus on COVID‐19
by: Seyedeh Hoda Alavizadeh, et al.
Published: (2022-05-01)